InSphero liver platforms combine fit-for-purpose 3D liver spheroid models, specially formulated media and cocktails, scalable delivery formats, and 3D-optimized protocols to ensure you get the most value from your investment in 3D in vitro technology.
Our advanced, pre-validated 3D liver models are engineered to help you assess toxicity risk earlier in the drug discovery process, and efficiently screen drugs for metabolic diseases of the liver, such as diet-induced steatosis, NASH, and fibrosis.
Liver Platforms
Liver Disease
Recapitulate metabolic disease states with human in vitro models engineered for HTS and efficacy testing
Liver Toxicology
Use advanced toxicology models that accurately reflect structure and physiology of in vivo liver